1-(Piperidin-3-yl)thymine amides as inhibitors of M. tuberculosis thymidylate kinase

J Enzyme Inhib Med Chem. 2019 Dec;34(1):1730-1739. doi: 10.1080/14756366.2019.1662790.

Abstract

A series of readily accessible 1-(piperidin-3-yl)thymine amides was designed, synthesised and evaluated as Mycobacterium tuberculosis TMPK (MtbTMPK) inhibitors. In line with the modelling results, most inhibitors showed reasonable MtbTMPK inhibitory activity. Compounds 4b and 4i were slightly more potent than the parent compound 3. Moreover, contrary to the latter, amide analogue 4g was active against the avirulent M. tuberculosis H37Ra strain (MIC50=35 µM). This finding opens avenues for future modifications.

Keywords: Mycobacterium tuberculosis; Thymidylate kinase; inhibitors; modelling.

MeSH terms

  • Amides / chemical synthesis
  • Amides / chemistry
  • Amides / pharmacology*
  • Antitubercular Agents / chemical synthesis
  • Antitubercular Agents / chemistry
  • Antitubercular Agents / pharmacology*
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / chemical synthesis
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / enzymology
  • Nucleoside-Phosphate Kinase / antagonists & inhibitors*
  • Nucleoside-Phosphate Kinase / metabolism
  • Structure-Activity Relationship
  • Thymine / chemical synthesis
  • Thymine / chemistry
  • Thymine / pharmacology*

Substances

  • Amides
  • Antitubercular Agents
  • Enzyme Inhibitors
  • Nucleoside-Phosphate Kinase
  • dTMP kinase
  • Thymine

Grants and funding

This work was supported by the China Scholarship Council (grant numbers 201607060021).